Yasmine Mona Hijazi, MD

Unless otherwise indicated, this information has been self-reported and has not been verified by the Board of Medicine.

None Reported

None Reported

Analysis of expression of melanoma associated antigens MART-1 and gp100 in metastatic melanoma cell lines and in-situ lesions
J Immunotherapy
19:192-205
Date: 01 1996

Application of molecular techniques to the diagnosis of microsporidial infection.
Emerging Infectious Diseases
2:183-191
Date: 01 1996

Comparative analysis of the in vivo expression of tyrosinase, MART-1/MelanA and gp100 in metastatic melanoma lesions
J Immunotherapy
Volume: 21
Date: 01 1998

Utility of the antibodies CA19-9, HBME-1 and thrombomodulin in the diagnosis of malignant mesotheliomas and adenocarcinomas in cytology
Ca ncer Cytopathology
84 ;101-108
Date: 02 1998

Heterogeneous expression of melanoma associated antigens and HLA-A2 in in-situ metastatic melanomas
Int J Cancer
75:517-524
Date: 04 1998

Metastatic malignant mesothelioma presenting as a salivary gland neoplasm
Acta Cytologica
42:818-820
Date: 05 1998

Melanoma-associated antigens recognized by T-cells
Cancer Cytopathology
87:37-42
Date: 01 1999

Distinction between PNET and Ewing's sarcoma is not predictive of tumor behaviour
Human Pathology
30:911-918
Date: 08 1999